Topamax (Topiramate) for Migraine Prevention: Benefits, Risks, Dosing, and Monitoring

Topiramate is an anticonvulsant FDA-approved for migraine prophylaxis and epilepsy.

Mechanism

Multiple: blocks voltage-gated Na+ channels, enhances GABAA activity, antagonizes AMPA/kainate glutamate receptors, inhibits carbonic anhydrase.

Dosing for Migraine

  • Start low (25 mg nightly), titrate weekly by 25 mg.
  • Target: 100 mg/day (divided BID) for most; some reach 200 mg/day.
  • Extended-release formulation available.

Benefits

  • Reduces migraine frequency, severity, duration.
  • May promote weight loss (unlike many preventives).

Common Side Effects

  • Paresthesias, cognitive slowing, word-finding difficulty, fatigue, anorexia, taste alteration.
  • Dose-related; often improve with slow titration.

Serious Risks

  • Acute angle-closure glaucoma (rare, urgent).
  • Metabolic acidosis (monitor bicarbonate).
  • Teratogenicity (cleft lip/palate) – contraindicated in pregnancy without strict contraception.
  • Kidney stones (hydration mitigates).

Monitoring

Baseline and periodic: weight, bicarbonate, creatinine, eye exam if symptoms. Counsel on contraception.

Migraine - Related Articles